+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atrovent"

Bronchodilators Market Report 2025 - Product Thumbnail Image

Bronchodilators Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
  • 7 Results (Page 1 of 1)
Loading Indicator

Atrovent is a brand name for the drug ipratropium bromide, a bronchodilator used to treat chronic obstructive pulmonary disease (COPD) and asthma. It is a long-acting anticholinergic drug that works by relaxing the muscles in the airways, allowing air to flow more freely. It is available in both an inhaler and a nebulizer solution. Atrovent is often used in combination with other respiratory drugs, such as corticosteroids and beta-agonists, to provide more effective relief from symptoms. Atrovent is one of the most commonly prescribed respiratory drugs in the world. It is used to treat a wide range of respiratory conditions, including COPD, asthma, and bronchitis. It is also used to prevent bronchospasm in people with COPD who are exposed to certain triggers, such as smoke or dust. The Atrovent market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include GlaxoSmithKline, Boehringer Ingelheim, Merck, and Teva Pharmaceuticals. Show Less Read more